FDA MedWatch – Certain Over-the-Counter Products Sold at Family Dollar Stores: Recall

TOPIC: Certain Over-the-Counter Products Sold at Family Dollar Stores: Recall – Due to Product Being Stored Outside of Labeled Temperature Requirements

AUDIENCE: Consumer, Health Professional 

ISSUE: Family Dollar is initiating a recall of certain products regulated by the FDA that were stored and inadvertently shipped to certain stores on or around May 1, 2022 through June 10, 2022 due to product being stored outside of labeled temperature requirements. This notice covers the recall of Over-the-Counter Medical Devices. 

Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product.

To date, Family Dollar has not received any consumer complaints or reports of illness related to this recall. 

For more information about this recall, click on the red button “Read Recall” below.

BACKGROUND: This recall does not apply to Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, Washington, Alaska, or Hawaii as Family Dollar does not have any stores in Alaska or Hawaii and no Family Dollar stores in any of the other states received any products subject to this recall.

RECOMMENDATIONS: 

• Consumers should contact their physician or health care provider if they have experienced any problems that may be related to using these products.
• Consumers who may have bought affected product may return such product to the Family Dollar store where they were purchased without receipt.
• Consumers with questions regarding this recall may contact Family Dollar Customer Service.

Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Follow us on Twitter at @FDAMedWatch